Dear Editor,
Loss of function of glucose-6-phosphate dehydrogenase (G6PD) represents the most common inborn error of metabolism throughout the world which is known as G6PD-deficiency affecting an estimated 400 million people.1 Prolonged neonatal jaundice and hemolytic anemia are common clinical manifestations. Infections, ingestion of fava beans, and some drugs can trigger life-threatening hemolytic anemia. G6PD is the first enzyme of the pentose phosphate pathway that converts Ī±-D-glucose-6-phospate into D-glucono-1,5-lactone-6-phosphate and is involved in the generation of NADPH. As erythrocytes lack the citric acid cycle, the pentose phosphate shunt is the only source of NADPH. NADPH is required for the generation of reduced glutathione, which is important for the protection against oxidative damage. As the G6PD gene is located at the X-chromosome at Xq28,2 the disease is recessively inherited in males. Some 140 missense mutations leading to amino-acid substitutions and in a few cases base pair deletions that do not produce frame shifts are known.3 Few splicing mutations have been documented.4, 5
Recently, Fico et al.6 stated that āfor the first time a role for G6PD in the protection from redox imbalance-induced apoptosis and necrosis has been clearly assignedā in a paper published by them. In fact, this has already been reported in 1995 by us.7 Since glutathione represents a cellular protectant against oxidative damage, which inhibits apoptosis, we hypothesized at that time that nucleated cells of G6PD-deficient patients should be more susceptible to DNA damage and apoptosis induced by oxidative stress. We reported that peripheral mononuclear cells (PBMC) from a G6PD-deficient male showed significantly higher apoptotic rates upon challenge by cytostatic drugs (daunorubicin), gamma-irradiation, or glucocorticoids (dexamethasone) than PBMC from healthy males.7 The induction of oxidative stress/generation of reactive oxygen species by all three agents has been reported.8, 9, 10, 11, 12, 13, 14 This implies that diverse ROS-generating agents affect white blood cells of G6PD-deficient patients leading to apoptosis due to insufficient protection from oxidative damage by reduced glutathione. We used PBMC of a German variant of G6PD deficiency, G6PD Aachen. This variant has originally been described by Kahn et al.15 The mutation in the G6PD Aachen variant has been determined by us previously.16 A mutation 1089C>G results in a predicted amino-acid change 363Asn>Lys. The 1089C>G point mutation is unique, but produces the identical amino-acid change found in another variant of G6PD deficiency, G6PD Loma Linda. The 363Asn>Lys exchange in G6PD Loma Linda is caused by a 1089C>A mutation.17 Using the available three-dimensional structure of the human G6PD tetrameric protein complex,18 the location of the point mutation of amino acid 363 in G6PD Aachen is found at the surface of a monomer in close proximity to NADP+ and more than 20āĆ away from the glucose-6-phosphate-binding site (data not shown). It can be speculated that this residue may be involved in NADP+ binding that in turn is required for tetramer stability.18 Thus, Arg363 may be required to indirectly maintain the structural integrity of the functional unit. Replacing it with a positively charged Lys residue would lead to chargeācharge repulsion between Lys363 and NADP+, thus affecting NADP+ binding and tetramer formation.
In the same year as we initially reported on the increased induction of apoptosis in G6PD-deficient cells, another group reported that G6PD is essential for defense against oxidative stress using G6PD knockout mice.19 Knockout clones of embryonic stem cells were extremely sensitive to hydrogen peroxide and to the sulfydryl group oxidizing agent, diamide. In a subsequent study, we analyzed whether increased induction of apoptosis correlated with increased DNA damage in G6PD-deficient PBMC.20 In PBMC of three males of the G6PD Aachen variant and one G6PD-deficient male from another family coming from Iran, we found that UV light induced more DNA damage and more apoptosis than in PBMC of healthy male subjects. PBMC of heterozygote females showed intermediate rates of DNA damage and apoptosis. We concluded that increased DNA damage and apoptosis may be a result of increased oxidative stress in G6PD-deficient patients. UV radiation is known to induce DNA damage and apoptosis by the generation of reactive oxygen species.21, 22, 23, 24 Interestingly, UV radiation induces hemolysis ā a major complication in G6PD deficiency ā which is reversible by the addition of glutathione.25 Recently, Mesbah-Namin et al.26 hypothesized that failure to detoxify hydrogen peroxide in G6PD-deficient leukocytes could induce primary DNA damage. Using the comet assay, these authors found that PBMC of 36 infants suffering from the Mediterranean variant of G6PD deficiency showed a significantly higher level of DNA stand breakage than PBMC of healthy control persons.
References
Miwa S and Fujii H (1996) Am. J. Hematol. 51: 122ā132
Pai GS et al. (1980) Proc. Natl. Acad. Sci. USA 77: 2810ā2813
Beutler E and Vulliamy TJ (2002) Blood Cells Mol. Dis. 28: 93ā103
Xu W et al. (1995) Blood 85: 257ā263
Efferth T et al. (2004) Blood 104: 2608
Fico A et al. (2004) Cell Death Differ. 11: 823ā831
Efferth T et al. (1995) J. Mol. Med. 73: 47ā49
Briehl MM et al. (1997) Oncol. Res. 9: 281ā285
MĆ¼ller I et al. (1998) Int. J. Mol. Med. 1: 491ā494
Taatjes DJ et al. (1998) Curr. Pharm. Des. 4: 203ā218
Tome ME and Briehl MM (2001) Cell Death Differ. 8: 953ā961
Tome ME et al. (2001) Cancer Res. 61: 2766ā2773
Miura Y (2004) J. Radiat. Res. 45: 357ā372
Spitz DR et al. (2004) Cancer Metast. Rev. 23: 311ā322
Kahn A et al. (1976) Hum Genet 32: 171ā180
Efferth T, Osieka R and Beutler E (2000) Blood Cells Mol. Dis. 26: 101ā104
Beutler E et al. (1991) J. Biol. Chem. 266: 4145ā4150
Au SWN et al. (2000) Structure 8: 293ā303
Pandolfi PP et al. (1995) EMBO J 14: 5209ā5215
Efferth T, Fabry U and Osieka R (2001) J. Leukoc. Biol. 69: 340ā342
Zhang X et al. (1997) Free Radic. Biol. Med. 23: 980ā985
Pourzand C and Tyrrell RM (1999) Photochem. Photobiol. 70: 380ā390
Kawanishi S, Hiraku Y and Oikawa S (2001) Mutat. Res. 488: 65ā76
Nishigori C, Hattori Y and Toyokuni S (2004) Antioxid. Redox Signal. 6: 561ā570
Godar DE et al. (1993) Photochem. Photobiol. 57: 1018ā1026
Mesbah-Namin SA, Nemati A and Tiraihi T (2004) Mutat. Res. 568: 179ā185
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Efferth, T., Schwarzl, S., Smith, J. et al. Role of glucose-6-phosphate dehydrogenase for oxidative stress and apoptosis. Cell Death Differ 13, 527ā528 (2006). https://doi.org/10.1038/sj.cdd.4401807
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4401807
This article is cited by
-
G6PD deficiencyādoes it alter the course of COVID-19 infections?
Annals of Hematology (2023)
-
Mild chronic exposure to pesticides alters physiological markers of honey bee health without perturbing the core gut microbiota
Scientific Reports (2022)
-
Biochemical comparison of two glucose 6-phosphate dehydrogenase isozymes from aĀ cold-adapted Pseudomonas mandelii
Extremophiles (2020)
-
Cisgenic Rvi6 scab-resistant apple lines show no differences in Rvi6 transcription when compared with conventionally bred cultivars
Planta (2016)